Company Data
Innoviva Inc.
Ticker
INVA
Current Price
$20.65 -1.01%
Market Cap
$1.5B
Price Target
Refer to Report
Volume
129.9K
52wk Range
$16.52 - $22.76
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance’s respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.